What is Cansortium Inc.?
Cansortium Inc. is a vertically integrated medical cannabis company headquartered in Miami, Florida, USA that markets its products under the Fluent™ brand. The company is licensed to produce and sell medical cannabis in Florida and Texas, and is licensed to sell medical cannabis in Pennsylvania.
Most of the Company’s existing business takes place in the State of Florida, where the company owns and operates cultivation and production facilities and currently operates 20 dispensaries. The Company owns and operates a cultivation and production facility and sells products via home deliveries in Texas and currently operates one dispensary in Pennsylvania. Additionally, the Company operates an outdoor cultivation facility in Michigan through a partnership with a Michigan license holder.
The Company’s medical cannabis products are offered in oral drops, capsules, suppositories, topicals, syringes, dried flower, pre-rolls and cartridges. All of its products are marketed under the Fluent™ brand name, which was launched in May 2019 to convey the Company’s commitment to gaining a deeper understanding of cannabis’ potential positive impacts on human health and wellness. Prior to the launch of the Fluent brand the Company had operated under the Knox Medical™ brand. In Pennsylvania, the Company’s product portfolio includes a variety of third-party branded medical cannabis products.
What year was Cansortium founded?
Cansortium was founded in April 2015.
Where is Cansortium’s corporate headquarters?
The company’s headquarters are located at:
82 NE 26th Street, Suite 110
Miami, Florida 33137
The Company’s registered office is located at:
295 The West Mall, Suite 600
Toronto, Ontario, M9C 4Z4.
Who are Cansortium’s top executives?
Please click here
to see the list of our top executives.
Where is Cansortium incorporated?
The company is incorporated in Ontario, Canada.
When did Cansortium go public?
Cansortium went public on the Canadian Securities Exchange on March 21, 2019.
On what exchange does the stock trade and what is the stock symbol?
Cansortium Inc.'s common shares and warrants trade on the CSE under the symbol "TIUM.U" and "TIUM.WT.U", respectively, and on the OTCQB Venture Market under the symbol (OTCQB: CNTMF).
Where can I get a copy of materials filed with the Canadian Securities Administration?
All of the company’s public filings are available at www.sedar.com
How can I buy the company’s common stock?
The company’s stock can be purchased through registered stockbrokers or through online stock brokerage services for self-directed investors.
Can I purchase stock directly from the company?
No, but the stock can be purchased through registered stock brokerages, including online firms.
Does Cansortium offer a Direct Stock Purchase Plan (DSPP or DRIP)?
At this time, the company does not offer a direct stock purchase plan.
Does Cansortium pay a dividend?
At this time, the company does not pay a dividend.
What is Cansortium’s fiscal year-end?
The company’s fiscal year ends on December 31.
What is Cansortium’s cusip?
The company’s cusip is 13809L109.
Who is Cansortium’s transfer agent?
Odyssey Trust Company with principal offices in Calgary, Alberta and Vancouver, British Columbia.
Who are Cansortium’s independent auditors?
How can I sign up to receive email alerts from the company?
Please click here
to sign up for our email alerts.
How do I contact Investor Relations for additional information?
Please click here
to contact our investor relations team.